rs370918174

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BA1BS3

This summary comes from the ClinGen Evidence Repository: PTEN c.210-39A>G (IVS3-39A>G) meets criteria to be classified as benign for PTEN Hamartoma Tumor syndrome in an autosomal dominant manner using modified ACMG criteria (PMID 30311380). Please see a summary of the rules and criteria codes in the “PTEN ACMG Specifications Summary” document (assertion method column).BA1: Allele frequency of 0.01015 (1.01%, 252/24,818 alleles) in the European (Finnish) subpopulation of the gnomAD cohort. (PMID 27535533) BS3: Intronic variant with RNA, mini-gene, or other splicing assay demonstrating no splicing impact. (PMID 28677221) LINK:https://erepo.genome.network/evrepo/ui/classification/CA059509/MONDO:0017623/003

Frequency

Genomes: 𝑓 0.0018 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 12 hom. )

Consequence

PTEN
NM_000314.8 intron

Scores

2

Clinical Significance

Benign reviewed by expert panel U:1B:7

Conservation

PhyloP100: 1.20

Publications

1 publications found
Variant links:
Genes affected
PTEN (HGNC:9588): (phosphatase and tensin homolog) This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]
PTEN Gene-Disease associations (from GenCC):
  • Cowden syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • PTEN hamartoma tumor syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • macrocephaly-autism syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
  • renal cell carcinoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • leiomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • activated PI3K-delta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Bannayan-Riley-Ruvalcaba syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lhermitte-Duclos disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Proteus-like syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • glioma susceptibility 2
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BS3
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000314.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTEN
NM_000314.8
MANE Select
c.210-39A>G
intron
N/ANP_000305.3
PTEN
NM_001304717.5
c.729-39A>G
intron
N/ANP_001291646.4
PTEN
NM_001304718.2
c.-541-39A>G
intron
N/ANP_001291647.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTEN
ENST00000371953.8
TSL:1 MANE Select
c.210-39A>G
intron
N/AENSP00000361021.3P60484-1
PTEN
ENST00000693560.1
c.729-39A>G
intron
N/AENSP00000509861.1A0A8I5KSF9
PTEN
ENST00000700029.2
c.210-39A>G
intron
N/AENSP00000514759.2A0A8V8TPK6

Frequencies

GnomAD3 genomes
AF:
0.00181
AC:
274
AN:
151760
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000921
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00393
Gnomad FIN
AF:
0.00998
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00182
Gnomad OTH
AF:
0.000958
GnomAD2 exomes
AF:
0.00251
AC:
614
AN:
244962
AF XY:
0.00287
show subpopulations
Gnomad AFR exome
AF:
0.000316
Gnomad AMR exome
AF:
0.000441
Gnomad ASJ exome
AF:
0.00222
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00983
Gnomad NFE exome
AF:
0.00179
Gnomad OTH exome
AF:
0.00235
GnomAD4 exome
AF:
0.00191
AC:
2651
AN:
1389108
Hom.:
12
Cov.:
26
AF XY:
0.00206
AC XY:
1432
AN XY:
694514
show subpopulations
African (AFR)
AF:
0.000220
AC:
7
AN:
31764
American (AMR)
AF:
0.000656
AC:
29
AN:
44198
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
66
AN:
25484
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38986
South Asian (SAS)
AF:
0.00486
AC:
410
AN:
84302
European-Finnish (FIN)
AF:
0.0106
AC:
559
AN:
52882
Middle Eastern (MID)
AF:
0.00379
AC:
21
AN:
5544
European-Non Finnish (NFE)
AF:
0.00140
AC:
1463
AN:
1048120
Other (OTH)
AF:
0.00166
AC:
96
AN:
57828
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
124
248
371
495
619
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00180
AC:
274
AN:
151878
Hom.:
1
Cov.:
32
AF XY:
0.00214
AC XY:
159
AN XY:
74248
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41540
American (AMR)
AF:
0.000920
AC:
14
AN:
15220
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3462
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00394
AC:
19
AN:
4826
European-Finnish (FIN)
AF:
0.00998
AC:
106
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00182
AC:
123
AN:
67714
Other (OTH)
AF:
0.000948
AC:
2
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
14
28
42
56
70
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00168
Hom.:
0
Bravo
AF:
0.000956
Asia WGS
AF:
0.000870
AC:
3
AN:
3464

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
not specified (2)
-
1
-
Cowden syndrome 1 (1)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
-
1
PTEN hamartoma tumor syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
6.7
DANN
Benign
0.67
PhyloP100
1.2
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs370918174; hg19: chr10-89690764; API